Neuroptics
Irvine, US · Founded 1995 · 83 employees on LinkedIn · 1 known investors
Find your way into Neuroptics
Sign up to see every warm intro you have to Neuroptics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Neuroptics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NeurOptics develops pupillometry technologies for clinical decision-making in critical care, neurology, neurosurgery, and emergency medicine. The company serves medical professionals and clinical researchers globally.
Founders & leadership
Board

Investors · 1
Reported raises · per SEC filings
Form D private placements$1.8M disclosed across 3 rounds · 2014–2016
▶$500KraisedApr 2016 · 7 investors · Other Health CareRule 506(b)
- Kamran SiminouExecutive Officer, Director
- Bob MellenDirector
- Joseph KianiDirector
- William WorthenExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $500K
- Proceeds to insiders
- $25K
- First sale
- Apr 2016
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$50KraisedSep 2015 · 1 investors · Other Health CareRule 506(b)
- Kamran SiminouExecutive Officer, Director
- Joseph KianiDirector
- William WorthenExecutive Officer, Director
- Bob MellenDirector
- Offering amount
- $600K
- Amount sold
- $50K
- Proceeds to insiders
- $60K
- First sale
- Aug 2015
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$1.2MraisedApr 2014 · 2 investors · Other Health CareRule 506(b)
- Kamran SiminouExecutive Officer, Director
- Willam WorthenExecutive Officer, Director
- Joseph KianiDirector
- Offering amount
- $2.5M
- Amount sold
- $1.2M
- Minimum investment
- $1
- Proceeds to insiders
- $125K
- First sale
- Mar 2014
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Neuroptics.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $1.3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $319.1K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Neuroptics do?
- NeurOptics develops pupillometry technologies for clinical decision-making in critical care, neurology, neurosurgery, and emergency medicine. The company serves medical professionals and clinical researchers globally.
- Who are Neuroptics's investors?
- Neuroptics's investors include Aphelion Capital.
- How much funding has Neuroptics raised?
- Neuroptics has disclosed $1.8M raised across 3 rounds.
- Where is Neuroptics headquartered?
- Neuroptics is headquartered in Irvine, US.



